CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (138)
2025
-
Efficient semi-supervised hierarchical training for segmenting choroidal vessels and other structures on OCT images of multiple sclerosis patients
Biomedical Signal Processing and Control, Vol. 100
2024
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 84
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
-
Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Frontiers in Neurology, Vol. 15
-
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores
Neurology: Neuroimmunology and NeuroInflammation, Vol. 11, Núm. 5
-
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks
Neurology, Vol. 103, Núm. 6
-
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals
Neurology and Therapy, Vol. 13, Núm. 4, pp. 1015-1038
-
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Frontiers in Immunology, Vol. 15
2023
-
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 15-21
-
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439
-
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis
Digital Health, Vol. 9
-
Diagnosis and treatment of progressive multiple sclerosis: A position paper
European Journal of Neurology, Vol. 30, Núm. 1, pp. 9-21
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
-
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 5-13
-
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
Multiple Sclerosis and Related Disorders, Vol. 69
-
Monitoring response to disease-modifying treatment in multiple sclerosis
Neurology Perspectives, Vol. 3, Núm. 2
-
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Frontiers in Neurology, Vol. 14
-
Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068
-
Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
Multiple Sclerosis and Related Disorders, Vol. 69